Dermatology and Venereology

Uzm. Dr. Ayşegül Tel Kankılıç

Doctor and researcher Ergani Devlet Hastanesi Diyarbakır
Psoriasis
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyDermatology and Venereologysaglik.gov.trFrom source
  • Department name at the sourceDeri ve Zührevi Hastalıklarsaglik.gov.trFrom source
  • InstitutionErgani Devlet Hastanesisaglik.gov.trFrom source
  • Area of workPsoriasisExtracted from 2 publications · Model version —From source
  • Publications7 publicationsORCID, OpenAlexFrom source
  • ORCID0009-0005-1163-357XORCIDFrom source
  • Last synchronised7 November 2026 00:03https://erganidh.saglik.gov.tr/TR-836780/doktorlarimiz.html#aysegul-tel-kankilicsaglik.gov.tr

Scientific work

Publications on Psoriasis

7 publications

  1. Artificial Intelligence‐Augmented Morphometric Reporting for Standardized Facial Aesthetic Treatment Planning: A Multi‐Rater Reliability Study

    Journal of Cosmetic Dermatology, 2026

    DOI 10.1111/jocd.70900 PMID 42144286 Open-access full textSource: ORCID

  2. The TyG Index as a surrogate marker of insulin resistance in Behçet’s disease: a case–control study

    Cutaneous and Ocular Toxicology, 2026

    DOI 10.1080/15569527.2026.2619505 PMID 41678271 Source: OpenAlex

  3. Multimodal Large Language Models for Acne Severity Assessment: A Systematic Benchmarking Study of Diagnostic Accuracy and Fitzpatrick Skin Type Bias Using Open-Access Dermatological Datasets

    2026

    DOI 10.17605/osf.io/56efw Open-access full textSource: OpenAlex

  4. Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study

    Figshare, 2026

    DOI 10.6084/m9.figshare.33113066 Open-access full textSource: OpenAlex

  5. Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study

    Expert Opinion on Biological Therapy, 2026

    DOI 10.1080/14712598.2026.2712432 PMID 42524890 Source: OpenAlex

  6. Reconciling molecular persistence and functional recovery: A hybrid four-layer computational model of botulinum neurotoxin A

    Toxicon, 2026

    DOI 10.1016/j.toxicon.2026.109264 PMID 42624296 Source: OpenAlex

  7. Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy

    Cutaneous and Ocular Toxicology, 2025

    DOI 10.1080/15569527.2025.2475444 PMID 40056433 1 citation (OpenAlex) Source: OpenAlex